The largest database of trusted experimental protocols

1 864 protocols using golgiplug

1

SARS-CoV-2 Spike Protein Peptide Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from heparinized whole blood using Ficoll–Paque (GE Healthcare, Singapore). Then, PBMCs from I-I-I were treated with the peptide pool containing 384 15-mer peptides spanning the antigen region of spike (S) protein (250 nM per peptide) in presence of 10 U/mL recombinant interleukin-2 (rIL-2) and 1 μM GolgiPlug (BD Biosciences, San Diego, CA) for 16 h at 37 °C, 5% CO2. PBMCs from BA.5 infection were treated with the peptide pool containing 487 15-mer peptides spanning the antigen region of spike (S), membrane (M), nucleocapsid (N), and envelope (E) proteins (250 nM per peptide) in presence of 10 U/mL rIL-2 and 1 μM GolgiPlug (BD Biosciences, San Diego, CA) for 16 h at 37 °C, 5% CO2. RPMI 1640 medium (Gibco, Waltham, MA) supplemented with 10% heat-inactivated FBS (Biological Industries, Israel Beit-Haemek), 100 U/mL penicillin (Gibco, Waltham, MA), 0.1 mg/mL streptomycin (Gibco, Waltham, MA), 10 U/mL rIL-2, and 0.01% DMSO (Sigma, Saint Louis, MO) was used as subtraction control.
+ Open protocol
+ Expand
2

Comprehensive Immune Phenotyping of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were plated and stained for 20 min at 4 °C with a combination of fluorescently labeled antibodies specific for surface markers including CD8α (53–6.7), CD25 (PC61.5), CD11a (M17/4), CD43glyco (1B11), CD44 (IM7) CD49a (Ha31/8), CD62L (MEL-14), CD69 (H1.2F3), CD103 (2E7), CD122 (5H4), CXCR3 (CXCR3–173), CXCR6 (SA051D1), CX3CR1 (SA011F11), KLRG1 (2F1), Thy1.1 (OX-7 or HIS51) and fixable viability stain (BD Horizon). Antibodies were purchased from BD Bioscience, BioLegend, eBioscience/Thermo Fischer Scientific, or Tonbo biosciences. Cells were fixed with BD Cytofix (BD Biosciences).
To asses cytokine production, single cells suspensions were plated in the absence (no stim) or in the presence 1 μM OVA(257–264) peptide in the presence of GolgiPlug (BD Bioscience) for 5 h at 37 °C or detected directly ex vivo in the absence of GolgiPlug. Cells were stained for surface molecules including fixable viability stain (BD Horizon), fixed and permeabilized using the transcription factor staining buffer kit (Thermo Fisher Scientific) and stained for cytokines including IFN-γ (XMG1.2), TNF (MP6-XT22), and IL-2 (JES6–5H4).
All samples were acquired using LSRFortessa (BD Bioscience) and analyzed using FlowJo software, version 9.9.4 (FlowJo LLC).
+ Open protocol
+ Expand
3

Comprehensive Immune Phenotyping of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were plated and stained for 20 min at 4 °C with a combination of fluorescently labeled antibodies specific for surface markers including CD8α (53–6.7), CD25 (PC61.5), CD11a (M17/4), CD43glyco (1B11), CD44 (IM7) CD49a (Ha31/8), CD62L (MEL-14), CD69 (H1.2F3), CD103 (2E7), CD122 (5H4), CXCR3 (CXCR3–173), CXCR6 (SA051D1), CX3CR1 (SA011F11), KLRG1 (2F1), Thy1.1 (OX-7 or HIS51) and fixable viability stain (BD Horizon). Antibodies were purchased from BD Bioscience, BioLegend, eBioscience/Thermo Fischer Scientific, or Tonbo biosciences. Cells were fixed with BD Cytofix (BD Biosciences).
To asses cytokine production, single cells suspensions were plated in the absence (no stim) or in the presence 1 μM OVA(257–264) peptide in the presence of GolgiPlug (BD Bioscience) for 5 h at 37 °C or detected directly ex vivo in the absence of GolgiPlug. Cells were stained for surface molecules including fixable viability stain (BD Horizon), fixed and permeabilized using the transcription factor staining buffer kit (Thermo Fisher Scientific) and stained for cytokines including IFN-γ (XMG1.2), TNF (MP6-XT22), and IL-2 (JES6–5H4).
All samples were acquired using LSRFortessa (BD Bioscience) and analyzed using FlowJo software, version 9.9.4 (FlowJo LLC).
+ Open protocol
+ Expand
4

Intracellular Cytokine Staining of Liver Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intracellular cytokine staining was performed, as previously described (58) ; see the Supplementary Materials for greater detail. In short, liver lymphocytes were isolated after in situ phosphatebuffered saline perfusion of the liver via the portal vein and stimulated for 6 hours at 37°C with appropriate peptides at a final concentration of 1 g/ml (OVA peptides used were SIINFEKL and/ or ISQAVHAAHAEINEAGR and HBsAg H2-L d -dominant peptide used was IPQSLDSWWTSL; ProImmune) and GolgiPlug (1 g/ml; BD Biosciences) or left unstimulated in complete media and GolgiPlug for control.
Cells were subsequently surface-stained on ice (see the Supplementary Materials for detailed antibody list), and samples were acquired using an LSR II flow cytometer (BD Biosciences) or LSR-Fortessa (BD Biosciences) and analyzed with FlowJo version 9 or version 10.1 (Tree Star Inc.). Lymphocytes were gated on live, size, and singlet and subsequently gated on CD8 + T cells.
+ Open protocol
+ Expand
5

Polyfunctional NK Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs and dMCs were thawed and rested overnight in low dose IL-15 as described above. For stimulation by PMA/Ionomycin, 1 × 106 mononuclear cells were treated with eBioscience™ cell stimulation cocktail (Invitrogen) for 4 h in 96-well U bottom plates at 37 °C, 5% C02. Golgi Plug (BD Biosciences) and Golgi Stop (BD Biosciences) were added for the final 3 h of stimulation. For K562 stimulations, mononuclear cells were co-cultured with K562 target cells at a ratio of 10:1 for 6 h in 96-well U bottom plates at 37 °C, 5% CO2. Golgi Plug (BD Biosciences) and Golgi Stop (BD Biosciences) were added for the final 5 h of stimulation. Cells were then stained and acquired as outlined above. To analyse polyfunctional NK responses to stimulation, Lin− CD56+ subsets were manually gated on the tSNE plot to show dNK1 (c10–c13), dNK2 (c9), dNK3 (c5, c8), and pbNK (c1, c2) subsets. Boolean gating arrays were created using FlowJo to determine the frequency of cells within these subsets that stained for one, two, or three readouts. Readouts were defined as: CD107a and/or IFNγ and/or at least one of the cytokines MIP1α, MIP1β, GM-CSF, XCL1 (Cyto). Non-responding cells that expressed none of the functional readouts were excluded.
+ Open protocol
+ Expand
6

Modulation of Cytokine Production by miR-125b

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four million of the freshly purified human monocytes/naïve CD8 T cells were electroporated either with or without 1.5 μm of hsa-miR-125b miRCURY™ LNA inhibitor (EXIQON, Woburn, MA, USA) or Scramble-miR inhibitor Control (Negative control A, EXIQON). The electroporation was carried out using a P3 Primary Cell 96-well Nucleofector™ Kit (Lonza) following the manufacturer's instructions. Next day (16 h after transfection), monocytes were stimulated for 3 h with LPS (100 ng/mL) plus GolgiPlug™ (1 μL/mL; BD Biosciences, San Jose, CA, USA), and naïve CD8 T cells were stimulated by anti-CD3/CD28 antibodies for at 3 h in the presence of GolgiPlug. The levels of CCL4 in electroporated cells were determined by intracellular staining with anti-CCL4 (R&D systems) as described below.
+ Open protocol
+ Expand
7

T Cell Activation in Lymph Nodes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight- to 10-week-old mice were injected in the footpad with 100 mg of SEA. Nine days after immunization, draining and nondraining lymph nodes were isolated and crushed into complete RPMI. Cells were counted and plated in round-bottom plates and either stimulated with PMA (50 ng/ml) and ionomycin (1 µg/ml), with the addition of brefeldin A (GolgiPlug, BD) for 6 hours, or stimulated with SEA (20 µg/ml) at 37°C for 48 hours, and then additionally stimulated with PMA (50 ng/ml) and ionomycin (1 µg/ml), with the addition of brefeldin A (GolgiPlug, BD) at 37°C for 2 hours. Cells were stained for flow cytometry as described above.
+ Open protocol
+ Expand
8

Cytokine Production and Degranulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens were harvested from recipient mice at >60 days post-infection, and CD8 T cells were isolated using the Mouse CD8 T Lymphocyte Enrichment Set (BD Biosciences). Following isolation, T cells were plated at 106 cells per well in 96-well U bottom plates in T cell medium supplemented with 0.05 μg/mL SIINFEKL peptide to selectively activate OVA-specific T cells. Following a 4hr incubation, capacity of indicated T cell populations to either produce the indicated cytokines or to degranulate was assessed. To allow analysis of cytokine production, Brefeldin A (GolgiPlug™, BD Biosciences) was added 30 minutes after initiation of T cell stimulation. To allow analysis of degranulation, T cell medium was supplemented with anti-CD107a and anti- CD107b antibodies at the initiation of T cell stimulation, and Brefeldin A (GolgiPlug™, BD Biosciences) and Monensin (GolgiStop™, BD Biosciences) were added 30 minutes after initiation of T cell stimulation. At the end of the T cell stimulation period, cells were stained for KLRG1 and CD27 and prepared for flow cytometric analysis (see below).
+ Open protocol
+ Expand
9

Cytokine Production and Degranulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens were harvested from recipient mice at >60 days post-infection, and CD8 T cells were isolated using the Mouse CD8 T Lymphocyte Enrichment Set (BD Biosciences). Following isolation, T cells were plated at 106 cells per well in 96-well U bottom plates in T cell medium supplemented with 0.05 μg/mL SIINFEKL peptide to selectively activate OVA-specific T cells. Following a 4hr incubation, capacity of indicated T cell populations to either produce the indicated cytokines or to degranulate was assessed. To allow analysis of cytokine production, Brefeldin A (GolgiPlug™, BD Biosciences) was added 30 minutes after initiation of T cell stimulation. To allow analysis of degranulation, T cell medium was supplemented with anti-CD107a and anti- CD107b antibodies at the initiation of T cell stimulation, and Brefeldin A (GolgiPlug™, BD Biosciences) and Monensin (GolgiStop™, BD Biosciences) were added 30 minutes after initiation of T cell stimulation. At the end of the T cell stimulation period, cells were stained for KLRG1 and CD27 and prepared for flow cytometric analysis (see below).
+ Open protocol
+ Expand
10

Intracellular Cytokine Profiling of Murine Lung ILC2s

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine intracellular cytokine production by isolated murine lung ILC2s, sorted cells in complete ILC2 medium (see above) were stimulated in 96-well round-bottom plates (15,000 cells/well) for 48 h with medium only; recombinant murine IL-2, IL-7, IL-9, and IL-33 (10 ng/ml; R&D Systems); or combinations thereof. GolgiPlug (BD Biosciences) was added for the last 6 h of culture. To analyze cytokine production following in vivo stimulation, lung cell suspensions (1 × 106 cells/well in a 96-well plate) in complete ILC2 medium were stimulated with Cell Stimulation Cocktail (eBioscience) according to the manufacturer’s instructions in the presence of GolgiPlug (BD Biosciences). Cells were stained with respective surface antibodies and viability dye as described above, and intracellular cytokine staining was performed using the FoxP3/Transcription Factor Staining Buffer Set (eBioscience) according to the manufacturer’s protocol. Stained cells were acquired on a BD LSRFortessa™ Cell Analyzer (BD Biosciences) and analyzed using FlowJo X (BD Biosciences). All antibodies used for flow cytometry analyses are listed in Table 1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!